Search
Close this search box.

Search Results for: About

Study Shows Proactive Supplementation Keeps Bones Healthy

An epidemiological study has revealed an increase in bone mineral density in women and men over 60 in less than one decade. A new published in the Journal of Bone and Mineral Research has yielded findings demonstrating that continued education and encouragement about dietary supplement consumption works! The authors analyzed data from one of the … Continue reading Study Shows Proactive Supplementation Keeps Bones Healthy

An epidemiological study has revealed an increase in bone mineral density in women and men over 60 in less than one decade.

A new published in the Journal of Bone and Mineral Research has yielded findings demonstrating that continued education and encouragement about dietary supplement consumption works! The authors analyzed data from one of the longest-running epidemiological studies into osteoporosis – the Dubbo Osteoporosis Epidemiology Study (DOES). This study includes more than 3,000 adults 60 and older who were tracked for several years in two time sets: 1988-1992 and 1999-2001.

 

The results showed a dramatic difference in bone health between the two cohorts. The latter group showed a 3% increase in bone mineral density from the previous cohort. And the latter group had a 45% reduction in hip fractures. This improved bone mineral density status reflects a more proactive mindset to utilize available tools and lifestyle adaptation to protect bone health during aging. Since 2013, one tool has gained tremendous global awareness – Vitamin K2 as MK-7 (as MenaQ7®).

 

The DOES substantiates a landmark three-year study in healthy menopausal women who consumed 180 mcg MenaQ7 or placebo daily. Results were remarkable: the researchers found a statistically significant reduction in the rate at which age-related bone mineral density and content were lost in femoral neck (hip) and lumbar spine.

 

Taken together, the 2013 study and the epidemiological findings create a powerful case for K2 to be a required nutrient to support bone health.

New MenaQ7® Evidence Presented at the ESC Congress; further Solidifies Cardiovascular Benefits

Once again MenaQ7® is leading the efforts to validate the benefits of Vitamin K2 as MK-7 to support cardiovascular health. At the prestigious European Society of Cardiology Congress, PhD student from CARIM School for Cardiovascular Diseases at Maastricht University, Femke de Vries, presented an abstract from a post-hoc analysis of the previously published 1-year MenaQ7 … Continue reading New MenaQ7® Evidence Presented at the ESC Congress; further Solidifies Cardiovascular Benefits

Once again MenaQ7® is leading the efforts to validate the benefits of Vitamin K2 as MK-7 to support cardiovascular health. At the prestigious European Society of Cardiology Congress, PhD student from CARIM School for Cardiovascular Diseases at Maastricht University, Femke de Vries, presented an abstract from a post-hoc analysis of the previously published 1-year MenaQ7 cardiovascular study. The presentation sparked a lot of discussion about the publication of the post-hoc analysis expected later this year.

In the post-hoc analysis, the authors aimed to examine how supplementation of Vitamin K2 as MK-7 affected vascular stiffness in women going through pre-, peri-, and post-menopausal stages. The trial included 166 women (age 40-70 with low K2 status) who consumed 180 mcg MK-7 daily or placebo for one year.

Much-Needed Research on Heart Health in Women

Research on this specific demographic is critical. While cardiovascular disease has been considered a “man’s disease,” it is still the major cause of death in women over the age of 65, and research has been underrepresented.

 

The findings presented via the poster named “Beneficial Effects of One-Year Supplementation with Menaquinone-7 on Vascular Health and Blood Pressure in Post-Menopausal Women,” confirm a correlation between hormonal changes and their impact on the vasculature.

 

Post-menopausal women may experience heightened vascular stiffness, which can manifest as functional vascular damage. Arterial stiffness is a significant indicator of cardiovascular health, particularly in relation to blood pressure. Interestingly, it seems that enhancing one’s K2 status may positively influence both.

 

The abstract has been published in the European Heart Journal and is available on ESC 365, the cardiology knowledge hub. The post-hoc analysis will be published in a peer-reviewed journal later this year.

Get Your Science from the Source

At Gnosis, we are thrilled that our flag ship brand, MenaQ7, once again is leading the way in the validation of Vitamin K2 as MK-7’s critical role in supporting human health.

 

When it comes to formulating for heart health, we encourage you to get your science from the source and choose MenaQ7® Vitamin K2.

Prof Leon Schurgers on A4M Redefining Medicine Podcast

After this year’s A4M Spring Conference, Prof. Leon Schurgers sat with host Erika Schwartz, MD, to have an in-depth conversation about his research and how Vitamin K2 as MK-7 can be part of a holistic and integrative approach to health and well-being. Redefining Medicine is an intimate and personalized program that shows a different side … Continue reading Prof Leon Schurgers on A4M Redefining Medicine Podcast

After this year’s A4M Spring Conference, Prof. Leon Schurgers sat with host Erika Schwartz, MD, to have an in-depth conversation about his research and how Vitamin K2 as MK-7 can be part of a holistic and integrative approach to health and well-being.

Redefining Medicine is an intimate and personalized program that shows a different side of the practice of medicine. The conversation with Prof. Leon Schurgers did not fail to deliver.

 

Enjoy the podcast to learn how Prof. Schurgers work began with vitamin K, the facts that have been elucidated during his illustrious career, as well as a view of how he, as a researcher, works closely with clinicians at Maastricht University.

 

> Watch the Podcast

The Significance of Prioritizing Heart Health and the Impact of MenaQ7® Vitamin K2

The global concern surrounding cardiovascular health continues to grow, prompting many of us to explore the supportive benefits offered by dietary supplementation. In recent years, researchers have placed a significant emphasis on understanding the role of arterial stiffness in cardiovascular health. Additionally, they have made groundbreaking discoveries regarding the vitamin K-dependent protein Matrix Gla Protein … Continue reading The Significance of Prioritizing Heart Health and the Impact of MenaQ7® Vitamin K2

The global concern surrounding cardiovascular health continues to grow, prompting many of us to explore the supportive benefits offered by dietary supplementation. In recent years, researchers have placed a significant emphasis on understanding the role of arterial stiffness in cardiovascular health. Additionally, they have made groundbreaking discoveries regarding the vitamin K-dependent protein Matrix Gla Protein (MGP). Through its many clinical trials, MenaQ7® is the vitamin K2 brand shown to effectively activate this critical cardio-supporting protein.

Vitamin K2 and Matrix Gla Protein (MGP)

Matrix Gla Protein (MGP) stands out as the most powerful prohibitor of vascular calcification, provided that the body has sufficient Vitamin K2 to activate it. Unfortunately, with vitamin K2 being almost completely void from typical Western diets, it is no wonder most people have deficient or insufficient levels of vitamin K2.

 

The Clinically Proven Vitamin K2 as MK-7 for Heart Health

Enter MenaQ7®: the clinically proven Vitamin K2 as MK-7. Our pioneering studies – randomized, double-blind, placebo-controlled trials – have demonstrated the remarkable benefits of MenaQ7®. One groundbreaking study, over the course of three years, showed that daily consumption of a nutritional dose of 180 mcg of MenaQ7® inhibited age-related arterial stiffening and improved arterial elasticity — a key aspect of maintaining a healthy cardiovascular system.

 

By choosing MenaQ7® for your supplement brand, be assured your ingredient is backed by scientific evidence confirming it supports robust heart health.

 

Learn more about the power of MenaQ7® and how the essence of this ingredient meets the top selection criteria of supplement buyers: Proof that it works!

 

> Download Brochure

Unveiling the Benefits of MenaQ7® Vitamin K2 in Sports and Protein Powders  

For athletes, optimizing performance and maintaining peak health is of great importance. While protein powders have long been the go-to supplement  for muscle recovery and growth, the incorporation of additional key nutrients can unlock further benefits. One such valuable addition is MenaQ7® Vitamin K2, which offers clinically proven health benefits for bone and cardiovascular health … Continue reading Unveiling the Benefits of MenaQ7® Vitamin K2 in Sports and Protein Powders  

For athletes, optimizing performance and maintaining peak health is of great importance. While protein powders have long been the go-to supplement  for muscle recovery and growth, the incorporation of additional key nutrients can unlock further benefits. One such valuable addition is MenaQ7® Vitamin K2, which offers clinically proven health benefits for bone and cardiovascular health – key areas for sports and fitness enthusiasts, as well as for the weekend warrior that seeks to stay active for longer.

Strong, resilient bones are crucial for athletes to withstand the demands of challenging training, and although cardiovascular health is perhaps not the first thing that comes to mind in relation to sports performance, it plays a pivotal role in our foundational health and our overall fitness.

 

Today, consumers are increasingly focused on the validation of claimed benefits when purchasing supplements and functional foods. The demand for effective and clinically proven ingredients has never been higher. With MenaQ7®, you can confidently state its benefits as it is the only clinically proven Vitamin K2 as MK-7 for bone and heart health available in the market to date. Furthermore, preliminary data from recent research on MenaQ7® demonstrates its ability to counteract oxidative stress in smooth muscle cells and increase ATP production, revealing its potential for additional benefits.

 

To learn more about how incorporating MenaQ7® can diversify and add value to your sports portfolio, we invite you to download our brochure. The brochure includes a step-by-step guide on best practices for formulating vitamin K2 in protein powders, providing you with the best starting point for success.

 

> Download Your Step-By-Step Guide

Experience the New MenaQ7 K2 Brand Identity 

Creating the Vitamin K2 category almost 20 years ago, a new MenaQ7® brand identity earmarks the next era of K2. Gnosis by Lesaffre is excited to announce the new identity for its uniquely scientifically backed Vitamin K2 as MK-7: MenaQ7®â. The established K2 category creator with more than 22+ published human clinical trials, MenaQ7® as … Continue reading Experience the New MenaQ7 K2 Brand Identity 

Creating the Vitamin K2 category almost 20 years ago, a new MenaQ7® brand identity earmarks the next era of K2.

Gnosis by Lesaffre is excited to announce the new identity for its uniquely scientifically backed Vitamin K2 as MK-7: MenaQ7®â. The established K2 category creator with more than 22+ published human clinical trials, MenaQ7® as a brand has remained relatively unchanged for the past 14 years, with a keen focus on validated benefits for bone health in children and adults and cardiovascular health in adults. But in acquiring MenaQ7® in 2021, Gnosis recognized the growing potential of Vitamin K2 for more areas of health, marking the perfect time to introduce the new MenaQ7® Natural Vitamin K2 as MK-7.

 

“The foundation of clinical evidence using MenaQ7® is what built the Vitamin K2 category and shaped our understanding of this important nutrient as we know it today. We believe the brand has signified ‘Quality Confirmed by Science,’ which is why so many of our partners include the logo on their product labels, marketing collateral, and websites,” says Marc Philouze, Gnosis by Lesaffre General Manager. “Yet research is beckoning the continuation of that pioneering spirit, and more work must be done to confirm Vitamin K2’s expanding role in supporting other areas of health. To that end, we have decided to introduce a new logo and brand identity for this new journey.”

New Elements

Customers and the industry can expect no change in the core tenants of MenaQ7®: Science, Expertise, and Support. These pillars will anchor the brand on this new path of innovation, according to Philouze, which led to the “magnifying glass” component of the logo.

“The magnifying glass speaks to the curious spirit of discovery, and that quality and science must be meticulously sought,” he continues. “Curiosity is essential to usher Vitamin K2 into the future – illuminating new indications with technological innovations unlocking new consumer applications.”

Other new elements are the logo’s colors and tagline. The new logo emphasizes Gnosis’s dedication to natural processes that leave minimal environmental impact. To that end, the colors are softened and reversed from the traditional dark blue with a light green accent. And where MenaQ7® has long been “Vitamin K2 as MK-7,” the MenaQ7 logo tagline is now “Natural Vitamin K2 as MK-7.” 

“The visual identity introduced today has been designed to better connect with our customers and the industry, and represent the work we do, utilizing what nature has to offer and the protection of our planet’s resources,” concludes Philouze. “As we look to the future, we see nothing but promise and potential, particularly as the benefits of Vitamin K2 are expanding. Here, again, we will lead in that discovery with MenaQ7®.”

The new brand identity is reflected on the refreshed www.MenaQ7.com and will make the transition to quality finished products featuring MenaQ7®.

Brand identity- MenaQ7

>_______

About Gnosis by Lesaffre 

Gnosis by Lesaffre harnesses the power of microorganisms and biotransformation processes like fermentation to cultivate nutritional actives, probiotics, and nutritional and functional yeasts that benefit human health and well-being. The team draws on its focused research and application capabilities to collaborate with nutraceutical and pharmaceutical brands to develop game-changing products for their customers.  

Gnosis by Lesaffre – Exploring Life to Improve Living. http://www.GnosisByLesaffre.com

About Lesaffre 

A key global player in fermentation for more than a century, Lesaffre, with a 2.2-billion-euro turnover, and established on all continents, counts 10,700 employees and more than 70 nationalities. On the strength of this experience and diversity, we work with customers, partners, and researchers to find ever more relevant answers to the needs of food, health, naturalness, and respect for our environment. Thus, every day, we explore and reveal the infinite potential of microorganisms. To nourish 10 billion people, in a healthy way, in 2050 by making the most of our planet’s resources is a major and unprecedented issue. We believe fermentation is one of the most promising answers to this challenge.   

Lesaffre – Working together to better nourish and protect the planet.